These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Superoxide anion generation of human polymorphonuclear leukocytes in urine]. Goto H, Kiyota H. Kansenshogaku Zasshi; 1991 Jun; 65(6):718-24. PubMed ID: 1655917 [Abstract] [Full Text] [Related]
3. Effect of enoxacin, norfloxacin and pefloxacin on polymorphonuclear leukocytes chemiluminescence. Aquilini D, Bartoloni A, Paradisi F. J Chemother; 1991 Jan; 3 Suppl 1():116-8. PubMed ID: 12041743 [Abstract] [Full Text] [Related]
4. Effect of newer quinolones on the extra- and intra-cellular chemiluminescence response of human polymorphonuclear leucocytes. Aoki M, Ono Y, Kunii O, Goldstein E. J Antimicrob Chemother; 1994 Sep; 34(3):383-90. PubMed ID: 7829412 [Abstract] [Full Text] [Related]
6. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans]. Renaudin H, Quentin C, de Barbeyrac B, Bebear C. Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430 [Abstract] [Full Text] [Related]
7. Effects of enoxacin, ofloxacin and norfloxacin on theophylline disposition in humans. Sano M, Kawakatsu K, Ohkita C, Yamamoto I, Takeyama M, Yamashina H, Goto M. Eur J Clin Pharmacol; 1988 May; 35(2):161-5. PubMed ID: 3191935 [Abstract] [Full Text] [Related]
8. Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition. Barnett G, Segura J, de la Torre R, Carbó M. Eur J Clin Pharmacol; 1990 May; 39(1):63-9. PubMed ID: 2177401 [Abstract] [Full Text] [Related]
9. Frequency and expression of mutational resistance to the 4-quinolone antibacterials. Smith JT. Scand J Infect Dis Suppl; 1986 May; 49():115-23. PubMed ID: 3547618 [Abstract] [Full Text] [Related]
10. Effects of quinolones on granulocyte function in vitro. Boogaerts MA, Malbrain S, Scheers W, Verwilghen RL. Infection; 1986 May; 14 Suppl 4():S258-62. PubMed ID: 3469158 [Abstract] [Full Text] [Related]
11. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates. Bassey CM, Baltch AL, Smith RP. J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401 [Abstract] [Full Text] [Related]
12. Corneal and scleral permeability of quinolones--a pharmacokinetics study. Tai MC, Lu DW, Chiang CH. J Ocul Pharmacol Ther; 2003 Dec; 19(6):547-54. PubMed ID: 14733712 [Abstract] [Full Text] [Related]
18. Acetaminophen inhibits the human polymorphonuclear leukocyte function in vitro. Shalabi EA. Immunopharmacology; 1992 Nov; 24(1):37-45. PubMed ID: 1333457 [Abstract] [Full Text] [Related]
19. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens. Naber KG, Well M, Hollauer K, Kirchbauer D, Witte W. Chemotherapy; 1998 Nov; 44(2):77-84. PubMed ID: 9551236 [Abstract] [Full Text] [Related]
20. Overview of the fluoroquinolone antibiotics. Just PM. Pharmacotherapy; 1993 Nov; 13(2 Pt 2):4S-17S. PubMed ID: 8386356 [Abstract] [Full Text] [Related] Page: [Next] [New Search]